These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28516292)

  • 1. LiMAx Test Improves Diagnosis of Chemotherapy-Associated Liver Injury Before Resection of Colorectal Liver Metastases.
    Lock JF; Westphal T; Rubin T; Malinowski M; Schulz A; Jara M; Bednarsch J; Stockmann M
    Ann Surg Oncol; 2017 Sep; 24(9):2447-2455. PubMed ID: 28516292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive diagnosis of chemotherapy induced liver injury by LiMAx test--two case reports and a review of the literature.
    Bednarsch J; Jara M; Lock JF; Malinowski M; Pratschke J; Stockmann M
    BMC Res Notes; 2015 Mar; 8():99. PubMed ID: 25889706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced liver injury in metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis is associated with preoperative chemotherapy.
    Ryan P; Nanji S; Pollett A; Moore M; Moulton CA; Gallinger S; Guindi M
    Am J Surg Pathol; 2010 Jun; 34(6):784-91. PubMed ID: 20421779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience.
    Wolf PS; Park JO; Bao F; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Kingham TP; Gönen M; Kemeny N; Shia J; D'Angelica MI
    J Am Coll Surg; 2013 Jan; 216(1):41-9. PubMed ID: 23041049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients.
    Komori H; Beppu T; Baba Y; Horino K; Imsung C; Masuda T; Hayashi H; Okabe H; Ootao R; Watanabe M; Takamori H; Iyama K; Baba H
    Int J Clin Oncol; 2010 Jun; 15(3):263-70. PubMed ID: 20238233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oxaliplatin-based chemotherapy on liver function--an analysis of impact and functional recovery using the LiMAx test.
    Jara M; Bednarsch J; Malinowski M; Pratschke J; Stockmann M
    Langenbecks Arch Surg; 2016 Feb; 401(1):33-41. PubMed ID: 26507639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.
    Morris-Stiff G; White AD; Gomez D; Cameron IC; Farid S; Toogood GJ; Lodge JP; Prasad KR
    Eur J Surg Oncol; 2014 Aug; 40(8):1016-20. PubMed ID: 24370284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological features and severity of oxaliplatin-induced liver injury and clinical associations.
    Nalbantoglu IL; Tan BR; Linehan DC; Gao F; Brunt EM
    J Dig Dis; 2014 Oct; 15(10):553-60. PubMed ID: 25060628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival.
    Viganò L; Capussotti L; De Rosa G; De Saussure WO; Mentha G; Rubbia-Brandt L
    Ann Surg; 2013 Nov; 258(5):731-40; discussion 741-2. PubMed ID: 24045448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases.
    Khan AZ; Morris-Stiff G; Makuuchi M
    J Hepatobiliary Pancreat Surg; 2009; 16(2):137-44. PubMed ID: 19093069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases.
    Brouquet A; Benoist S; Julie C; Penna C; Beauchet A; Rougier P; Nordlinger B
    Surgery; 2009 Apr; 145(4):362-71. PubMed ID: 19303984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity.
    Pilgrim CH; Satgunaseelan L; Pham A; Murray W; Link E; Smith M; Usatoff V; Evans PM; Banting S; Thomson BN; Phillips WA; Michael M
    HPB (Oxford); 2012 May; 14(5):333-40. PubMed ID: 22487071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing.
    Krieger PM; Tamandl D; Herberger B; Faybik P; Fleischmann E; Maresch J; Gruenberger T
    Ann Surg Oncol; 2011 Jun; 18(6):1644-50. PubMed ID: 21207168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases.
    Fernandez FG; Ritter J; Goodwin JW; Linehan DC; Hawkins WG; Strasberg SM
    J Am Coll Surg; 2005 Jun; 200(6):845-53. PubMed ID: 15922194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.
    Soubrane O; Brouquet A; Zalinski S; Terris B; Brézault C; Mallet V; Goldwasser F; Scatton O
    Ann Surg; 2010 Mar; 251(3):454-60. PubMed ID: 20160638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative chemotherapy and the outcome of liver resection for colorectal metastases.
    Hewes JC; Dighe S; Morris RW; Hutchins RR; Bhattacharya S; Davidson BR
    World J Surg; 2007 Feb; 31(2):353-64; discussion 365-6. PubMed ID: 17219289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis.
    Ji JH; Park SH; Lee J; Kim TW; Hong YS; Kim KP; Kim SY; Baek JY; Kang HJ; Shin SJ; Shim BY; Park YS
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):223-30. PubMed ID: 23689915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-induced liver injury in metastatic colorectal cancer: about 48 cases.
    Limaiem F; Bouraoui S
    Pan Afr Med J; 2018; 30():198. PubMed ID: 30455827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative assessment of chemotherapeutic associated liver injury based on indocyanine green retention test.
    Russolillo N; Langella S; Perotti S; Lo Tesoriere R; Forchino F; Ferrero A
    Int J Surg; 2016 Jul; 31():80-5. PubMed ID: 27260311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.